Department of Otorhinolaryngology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Institute for Yonsei Ear Science, Seoul 03722, Republic of Korea.
Theranostics. 2022 Feb 28;12(5):2465-2482. doi: 10.7150/thno.67781. eCollection 2022.
Outer hair cell (OHC) degeneration is a major cause of progressive hearing loss and presbycusis. Despite the high prevalence of these disorders, targeted therapy is currently not available. We generated a mouse model harboring to recapitulate DFNA2, a common genetic form of progressive hearing loss accompanied by OHC degeneration. After comprehensive optimization of guide RNAs, Cas9s, vehicles, and delivery routes, we applied gene editing strategy to disrupt the dominant-negative allele in and prevent progressive hearing loss. gene editing using a dual adeno-associated virus package targeting OHCs significantly improved auditory thresholds in auditory brainstem response and distortion-product otoacoustic emission. In addition, we developed a new live-cell imaging technique using thallium ions to investigate the membrane potential of OHCs and successfully demonstrated that mutant allele disruption resulted in more hyperpolarized OHCs, indicating elevated KCNQ4 channel activity. These findings can facilitate the development of targeted therapies for DFNA2 and support the use of CRISPR-based gene therapy to rectify defects in OHCs.
外毛细胞(OHC)变性是进行性听力损失和老年性聋的主要原因。尽管这些疾病的发病率很高,但目前还没有靶向治疗方法。我们构建了一种携带突变的小鼠模型,该突变可模拟 DFNA2,这是一种常见的进行性听力损失的遗传形式,伴有 OHC 变性。在全面优化向导 RNA、Cas9、载体和递送途径后,我们应用基因编辑策略来破坏突变等位基因,并预防进行性听力损失。针对 OHC 的双腺相关病毒包的基因编辑显著改善了听觉脑干反应和畸变产物耳声发射中的听阈。此外,我们开发了一种使用铊离子的新型活细胞成像技术来研究 OHC 的膜电位,并成功证明突变等位基因的破坏导致更超极化的 OHC,表明 KCNQ4 通道活性升高。这些发现可以促进针对 DFNA2 的靶向治疗方法的发展,并支持使用基于 CRISPR 的基因治疗来纠正 OHC 的缺陷。